Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Almonty Announces Intention to Relocate to the United States (click to learn more) Benton Intersects 22.0 m Grading 7.47% Copper Including 8.0 m Grading 11.93% Copper (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Gitennes Exploration Inc V.GIT

Alternate Symbol(s):  GILXF

Metals & Mining Gold
Gitennes Exploration Inc. is a junior mineral exploration company, which is engaged in the business of exploring for and advancing mineral properties. It has two properties in the Sept-Iles region of Quebec where it is exploring for nickel, niobium and tantalum, and three gold properties in the Chapais-Chibougamau area of Quebec: New Mosher, JMW and Maxwell. All properties are 100% owned by the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:GIT)

Gitennes Prepares For Work On Quebec Properties, Hires Investor Relations

TheNewsWire 10 days ago

Gitennes Closes $1.5 Million Private Placement

TheNewsWire 12 days ago

Gitennes Closes First $1.315 Million of $1.5 Million Private Placement

TheNewsWire December 23, 2024

Gitennes Arranges Private Placement For Up To $1.5 Million

TheNewsWire December 4, 2024

Gitennes Announces AGSM Results and Management Changes

TheNewsWire November 29, 2024

Gitennes Announces Board of Director Changes

TheNewsWire October 25, 2024

Gitennes Announces Closing of Non-Brokered Private Placement

TheNewsWire October 10, 2024

Gitennes Announces Non-Brokered Private Placement

TheNewsWire September 19, 2024

Gitennes Announces Closing of Debt Settlements

TheNewsWire August 28, 2024
View More News ››

Opinion & Analysis (TSXV:GIT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:GIT)

RE:Obvious......

Well the new guys are doing a good job sl far
oneoone - December 9, 2024

Obvious......

New group is taking over the shell.... Explains the run up in price.....resignations.... Rolling $1.5 million into the deal VIA PP to...
ShortOnCash - December 9, 2024

RE:RE:RE:RE:RE:RE:If the price is genuine, could mean more than just

price keeps rising  news is needed
oneoone - December 9, 2024

RE:RE:RE:RE:RE:If the price is genuine, could mean more than just

Of course, I took a loss after the roll back, big time!
CriticalMind55 - December 4, 2024

RE:RE:RE:RE:If the price is genuine, could mean more than just

I dumped all my shares in this POS company, raising capital to pay themselves and some bills? no thank you.
CriticalMind55 - December 4, 2024

RE:RE:RE:If the price is genuine, could mean more than just

Nice price nice volume  Tell us why managment
oneoone - December 3, 2024
View more Bullboard ››

BioVaxys Technology Corp.

BioVaxys Technology Corp.

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving ...
View More »